Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 6080129, 5 pages
https://doi.org/10.1155/2017/6080129
Research Article

Structure-Activity Relationships of N-Cinnamoyl and Hydroxycinnamoyl Amides on α-Glucosidase Inhibition

1Faculty of Mathematics and Natural Sciences, South-West University “Neofit Rilski”, 66 Ivan Mihailov Str., 2700 Blagoevgrad, Bulgaria
2REQUIMTE-UCIBIO, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre s/n, 4169-007 Porto, Portugal
3Faculty of Science, Section of Chemistry, Charles University, Hlavova 2030/8, 12843 Prague 2, Czech Republic
4Faculty of Education, Department of Chemistry, Janos Selye University, Bratislavská Cesta 3322, 94501 Komárno, Slovakia

Correspondence should be addressed to Maya G. Chochkova; moc.oohay@2002gbayam

Received 6 March 2017; Revised 21 May 2017; Accepted 6 June 2017; Published 11 July 2017

Academic Editor: Albert Demonceau

Copyright © 2017 Maya G. Chochkova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Miller, G. R. Buettner, and S. D. Aust, “Transition metals as catalysts of autoxidation reactions,” Free Radical Biology and Medicine, vol. 8, no. 1, pp. 95–108, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Klatt and S. Lamas, “Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress,” European Journal of Biochemistry, vol. 267, no. 16, pp. 4928–4944, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Ridnour, J. S. Isenberg, M. G. Espey, D. D. Thomas, D. D. Roberts, and D. A. Wink, “Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 37, pp. 13147–13152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Ridnour, D. D. Thomas, D. Mancardi et al., “The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations,” Biological Chemistry, vol. 385, no. 1, pp. 1–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” The International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. B. Corry and M. L. Tuck, “Protection from vascular risk in diabetic hypertension,” Current Hypertension Reports, vol. 2, no. 2, pp. 154–159, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Park, K. Y. Hwang, Y. H. Kim, K. H. Oh, J. Y. Lee, and K. Kim, “Discovery and biological evaluation of novel α-glucosidase inhibitors with in vivo antidiabetic effect,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 13, pp. 3711–3715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Gao and J. Kawabata, “α-Glucosidase inhibition of 6-hydroxyflavones. Part 3: synthesis and evaluation of 2,3,4-trihydroxybenzoyl-containing flavonoid analogs and 6-aminoflavones as α-glucosidase inhibitors,” Bioorganic and Medicinal Chemistry, vol. 13, no. 5, pp. 1661–1671, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Hollander, X. Pi-Sunyer, and R. F. Coniff, “Acarbose in the treatment of type I diabetes,” Diabetes Care, vol. 20, no. 3, pp. 248–253, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Scott and C. M. Spencer, “Miglitol: A review of its therapeutic potential in type 2 diabetes mellitus,” Drugs, vol. 59, no. 3, pp. 521–549, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Y. Y. Cheng and R. G. Josse, “Intestinal absorption inhibitors for type 2 diabetes mellitus: Prevention and treatment,” Drug Discovery Today: Therapeutic Strategies, vol. 1, no. 2, pp. 201–206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mitrakou, N. Tountas, A. E. Raptis, R. J. Bauer, H. Schulz, and S. A. Raptis, “Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099- miglitol) in insulin-treated type 2 diabetes mellitus,” Diabetic Medicine, vol. 15, no. 8, pp. 657–660, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. C. P. Kordik and A. B. Reitz, “Pharmacological treatment of obesity: Therapeutic strategies,” Journal of Medicinal Chemistry, vol. 42, no. 2, pp. 181–201, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M.-J. Papandréou, R. Barbouche, R. Guieu, M. P. Kieny, and E. Fenouillet, “The α-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step,” Molecular Pharmacology, vol. 61, no. 1, pp. 186–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. P. S. Sunkara, D. L. Taylor, M. S. Kang et al., “Anti-HIV activity of castanospermine analogues,” The Lancet, vol. 333, no. 8648, article 1206, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Dettenhofer and X.-F. Yu, “Characterization of the Biosynthesis of Human Immunodeficiency Virus Type 1 Env from Infected T-cells and the Effects of Glucose Trimming of Env on Virion Infectivity,” Journal of Biological Chemistry, vol. 276, no. 8, pp. 5985–5991, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. G. S. Jacob, “Glycosylation inhibitors in biology and medicine,” Current Opinion in Structural Biology, vol. 5, no. 5, pp. 605–611, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Asano, A. Kato, and A. A. Watson, “Therapeutic applications of sugar-mimicking glycosidase inhibitors,” Mini Reviews in Medicinal Chemistry, vol. 1, no. 2, pp. 145–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Ganem, “Inhibitors of Carbohydrate-Processing Enzymes: Design and Synthesis of Sugar-Shaped Heterocycles,” Accounts of Chemical Research, vol. 29, no. 7, pp. 340–347, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Asano, “Glycosidase inhibitors: Update and perspectives on practical use,” Glycobiology, vol. 13, no. 10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Nishimura, “gem-Diamine 1-N-iminosugars and related iminosugars, candidate of therapeutic agents for tumor metastasis,” Current Topics in Medicinal Chemistry, vol. 3, no. 5, pp. 575–591, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. T. A. Houston and J. T. Blanchfield, “Back to (non)-basics: recent developments in neutral and charge-balanced glycosidase inhibitors,” Mini Reviews in Medicinal Chemistry, vol. 3, no. 7, pp. 669–678, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. D. D. Schmidt, W. Frommer, B. Junge et al., “α-Glucosidase inhibitors—new complex oligosaccharides of microbial origin,” Naturwissenschaften, vol. 64, no. 10, pp. 535-536, 1977. View at Publisher · View at Google Scholar · View at Scopus
  25. Drugs@FDA. U.S. Food and Drug Administration. August 2012. Retrieved 13 April 2013.
  26. T. Matsuo, H. Odaka, and H. Ikeda, “Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes,” The American Journal of Clinical Nutrition, vol. 55, no. 1, pp. 314S–317S, 1992. View at Google Scholar
  27. Anon, Global Status Report on Noncommunicable Diseases 2010, World Health Organization, Geneva, Switzerland, 2011.
  28. F.-L. Hsu, Y.-C. Chen, and J.-T. Cheng, “Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats,” Planta Medica, vol. 66, no. 3, pp. 228–230, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. P. K. Mukherjee, K. Maiti, K. Mukherjee, and P. J. Houghton, “Leads from Indian medicinal plants with hypoglycemic potentials,” Journal of Ethnopharmacology, vol. 106, no. 1, pp. 1–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Adisakwattana, K. Sookkongwaree, S. Roengsumran et al., “Structure-activity relationships of trans-cinnamic acid derivatives on α-glucosidase inhibition,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 11, pp. 2893–2896, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Adisakwattana, P. Chantarasinlapin, H. Thammarat, and S. Yibchok-Anun, “A series of cinnamic acid derivatives and their inhibitory activity on intestinal α-glucosidase,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 24, no. 5, pp. 1194–1200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Stoykova, M. Chochkova, P. Petrova, G. Ivanova, and Ts. Milkova, “Peptides,” in Proceedings of the 33rd European Peptide Symposium, E. Naydenova, T. Pajpanova, and D. Danalev, Eds., p. 51, European Peptide Society, Sofia, Bulgaria, 2014.
  33. M. Spasova, V. Kortenska-Kancheva, I. Totseva, G. Ivanova, L. Georgiev, and T. Milkova, “Synthesis of cinnamoyl and hydroxycinnamoyl amino acid conjugates and evaluation of their antioxidant activity,” Journal of Peptide Science, vol. 12, no. 5, pp. 369–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Georgiev, M. Chochkova, I. Totseva et al., “Anti-tyrosinase, antioxidant and antimicrobial activities of hydroxycinnamoylamides,” Medicinal Chemistry Research, vol. 22, no. 9, pp. 4173–4182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. W. C. Chan and P. D. White, Fmoc Solid Phase Peptide Synthesis, Oxford University Press, Oxford, UK, 2000.
  36. B. Mayur, S. Sandesh, S. Shruti, and S. Sung-Yum, “Antioxidant and-glucosidase inhibitory properties of Carpesium abrotanoides L,” Journal of Medicinal Plants Research, vol. 4, no. 15, pp. 1547–1553, 2010. View at Google Scholar
  37. M. Okuyama, A. Okuno, N. Shimizu, H. Mori, A. Kimura, and S. Chiba, “Carboxyl group of residue Asp647 as possible proton donor in catalytic reaction of α-glucosidase from Schizosaccharomyces pombe,” European Journal of Biochemistry, vol. 268, no. 8, pp. 2270–2280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. P.-H. Liang, W.-C. Cheng, Y.-L. Lee et al., “Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: New structures for antivirals and osteoarthritis,” ChemBioChem, vol. 7, no. 1, pp. 165–173, 2006. View at Publisher · View at Google Scholar · View at Scopus